Sector Chart Exelixis, Inc.

Stocks

EXEL

US30161Q1040

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 10:47:55 2026-09-11 EDT			5-day change	1st Jan Change
56.00 ^USD	-2.49%		-4.72%	+28.28%

09:15am	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Inflation Data Release	MT
08:21am	Exelixis, Inc. Extends FDA Review Period for Zanzalintinib New Drug Application in Combination with Atezolizumab for Metastatic Colorectal Cancer	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes